• SENSEX 76,917.85
    1,225.07 (+1.62%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
  • NSE
    1,814.50 1,878.00(%)
  • Jio Platforms
    1,440.80 1,490.00(%)
  • Bharti Airtel
    2,080.70 2,174.70(%)
  • Reliance Industries
    1,307.00 1,611.20(%)
  • BLS Polymers
    285.25 285.25(%)
  • Solar Industries
    20,860.00 22,630.05(%)
  • Multi Comm. Exc.
    3,537.00 3,537.00(%)
  • Aegis Logistics
    1,253.90 1,528.00(%)
  • SBI
    961.35 933.85(%)
  • HDFC Bank
    725.70 1,017.90(%)
  • Oil India
    451.30 395.75(%)
  • Garden Reach Sh.
    2,235.00 3,338.90(%)
  • Divi's Lab.
    10,035.00 10,035.00(%)
  • M & M Fin. Serv.
    267.15 415.00(%)
  • Sagility
    41.98 35.82(%)
  • SFC Enviro.
    424.85 424.85(%)
  • Mankind Pharma
    2,523.70 2,640.30(%)
  • M & M
    2,910.95 3,840.00(%)
  • Kanohar Elect.
    1,165.90 1,210.00(%)
  • Laurus Labs
    2,252.50 913.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Kabra Drugs Ltd Trading

  • Indian Private
  • BSE Code : 2908.0
  • ISIN : INE323K01017
15.83 0 (0.76%)
  • As on 03 Nov 2026 (EOD)

  • Today’s Low

    15.34

  • Today’s High

    16.37

  • Open

    15.80

  • Perv Close

    15.71

  • 52W Low

    15.30

  • 52W High

    35.52

Key Indicators

  • P/E(TTM)

    4.95

  • Mar.Cap (₹Cr.)

    37.53

  • Div & Yield %

    0.00

  • Book Value(₹)

    12.49

  • Debt-Equity Ratio

    0.76

  • AGM Date

    03-Nov-2026

  • EPS

    3.20

  • P/E Ratio

    4.95

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    37.53

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    23.71

  • BV (₹)

    12.50

  • Sales( ₹ in Cr.)

    92.74

  • NP (in Cr.)

    4.96

  • NP Var(%)

    557.0

  • Div%

    0.0

  • CPS (₹)

    2.10

  • EPS (₹)

    2.10

  • Traded Value (₹ in Lakhs)

    37.25

  • 52 Week High

    35.52

  • 52 Week Low

    15.30

  • Price BSE

    16.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    37.25

  • P/C Ratio

    7.50

  • P/E Ratio

    7.60

  • Price Vs.BV

    2.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 92.74 0.00 0.00 0.00 0.00 0.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 92.74 0.00 0.00 0.00 0.00 0.00
Other Income 0.49 0.64 0.00 0.01 0.00 0.00
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 93.23 0.64 0.00 0.01 0.00 0.00
EXPENDITURE :            
Raw Materials 83.66 0.00 0.00 0.00 0.00 0.00
Power and Fuel Cost 0.01 0.00 0.00 0.00 0.00 0.00
Employee Cost 1.47 0.69 0.40 0.23 0.09 0.05
Other Manufacturing Expenses 0.05 0.00 0.00 0.00 0.00 0.00
Selling and Administration Expenses 2.14 0.94 0.30 0.09 0.08 0.10
Miscellaneous Expenses 0.08 0.09 0.03 0.02 0.01 0.00
Employee Benefit Expenses 1.47 0.69 0.40 0.23 0.09 0.05
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 87.41 1.72 0.74 0.34 0.18 0.15
Operating Profit 5.82 -1.08 -0.74 -0.34 -0.18 -0.15
Interest 0.03 0.00 0.00 0.00 0.00 0.00
Gross Profit 5.79 -1.08 -0.74 -0.34 -0.18 -0.15
Depreciation 0.07 0.01 0.00 0.00 0.01 0.03
Profit Before Tax 5.72 -1.09 -0.74 -0.34 -0.19 -0.18
Current Tax 0.76 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.01 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 4.96 -1.09 -0.74 -0.34 -0.19 -0.18
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 4.96 -1.09 -0.74 -0.34 -0.19 -0.18
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -6.94 -5.86 -5.12 -4.78 -4.60 -4.42
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -1.98 -6.94 -5.86 -5.12 -4.78 -4.60
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 2.09 -0.46 -1.68 -0.77 -0.42 -0.41
Earnings Per Share(Adj)-Unit Curr 2.09 -0.46 -1.68 -0.77 -0.42 -
Book Value 12.49 10.40 -3.34 -1.67 -0.90 -0.47
Book Value(Adj)-Unit Curr 12.49 10.40 -3.34 -1.67 -0.90 -

Shareholding Pattern

  • Public Share Holding

    100.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 779,062 3.29 692,762 41
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 544,393 2.30 544,393 29
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 809,189 3.41 808,989 100
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 14,890,647 62.81 14,865,447 175
Individuals holding nominal share capital up to Rs. 1 lakh 6,654,840 28.07 5,347,139 9,377
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 23,707,850 100.00 22,288,449 9,727
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 23,707,850 100.00 22,288,449 9,727

Company Background

Kabra Drugs LtdTrading

  • Kabra Drugs Ltd
  • BSE Code : 2908.0
  • ISIN : INE323K01017

  • Incorporation Year

    1989

  • Registered Office

    270 Shastri Market Indore
    , Indore,
    Madhya Pradesh-452007

  • Telephone

  • FAX

  • Chairman

  • Managing Director

    N Aravind

  • Company Secretary

    Monika Sanwal

  • Auditor

    P P N AND COMPANY

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Ankit Consultancy Pvt Ltd
    Plot No. 60,
    Electronic Complex,Pardeshipura
    Mumbai - Indore - 452010

Kabra Drugs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Kabra Drugs 15.83 93.23 92.74 4.95 20.08
Abbott India 25,805.30 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,340.60 2,304.07 2,275.58 93.45 27.86
Glaxosmi. Pharma 2,573.30 3,932.76 3,790.20 41.11 58.17
Novartis India 1,719.85 393.10 354.33 43.43 15.94
Cipla 1,392.20 20,102.60 18,979.95 42.43 13.88
Bliss GVS Pharma 637.90 773.53 729.81 41.58 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 427.55 474.15 450.25 19.96 18.77
Guj. Themis Bio. 377.25 168.25 165.82 100.87 18.05
Ambalal Sarabhai 34.90 19.52 3.94 64.63 6.77